Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» uveal melanoma
uveal melanoma
Delcath Gets FDA Approval for Cancer Drug-Device Combo 10 Years After Rejection
BioSpace
Wed, 08/16/23 - 10:21 am
Delcath
drug-device combos
FDA
Hepzato
uveal melanoma
Foghorn Abandons Uveal Melanoma Program after Subpar Phase I Results
BioSpace
Thu, 06/29/23 - 11:48 am
Foghorn Therapeutics
uveal melanoma
AML
FHD-286
FDA grants fast track designation for IDEAYA’s uveal melanoma therapy
Pharmaceutical Business Review
Tue, 12/6/22 - 10:29 am
IDEAYA Biosciences
darovasertib
uveal melanoma
FDA
Immunocore soars 17% as FDA approves Kimmtrak for uveal melanoma
Seeking Alpha
Wed, 01/26/22 - 10:53 am
Immunocore
Kimmtrak
FDA
uveal melanoma
Immunocore gets FDA breakthrough nod for eye melanoma drug ahead of planned Q3 filing
Fierce Biotech
Fri, 02/19/21 - 10:28 am
Immunocore
FDA
uveal melanoma
breakthrough therapy
tebentafusp
Hot on the heels of a positive PhIII, Immunocore hauls in $175M as it hunts its first TCR OK
Endpoints
Mon, 01/11/21 - 10:38 am
Immunocore
clinical trials
tebentafusp
uveal melanoma
AstraZeneca drug selumetinib fails in uveal melanoma trial
Yahoo/Reuters
Wed, 07/22/15 - 08:31 am
AstraZeneca
selumetinib
uveal melanoma